During the past decade, S.C Oncocenter Oncologie Clinica S.R.L conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 11 clinical trials were completed, i.e. on average, 68.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 10 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "S.C Oncocenter Oncologie Clinica S.R.L" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "EMD Serono Research & Development Institute, Inc." with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Can-Fite BioPharma" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "S.C Oncocenter Oncologie Clinica S.R.L" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "BeiGene" with 1 trials as a collaborator, "Caris Life Sciences" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Foundation Medicine, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "S.C Oncocenter Oncologie Clinica S.R.L" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Hepatocellular Carcinoma" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Bone Metastasis" (1 trials) and "Cancer Pain" (1 trials). Many other conditions were trialed in "S.C Oncocenter Oncologie Clinica S.R.L" in a lesser frequency.

Most popular intervention types in "S.C Oncocenter Oncologie Clinica S.R.L" are "Drug" (16 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (4 trials), "Placebo" (4 trials), "Avelumab" (3 trials), "Carboplatin" (3 trials) and "Cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "S.C Oncocenter Oncologie Clinica S.R.L" are 16 trials for "All" genders.

Currently, there are NaN active trials in "S.C Oncocenter Oncologie Clinica S.R.L". 1 are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in S.C Oncocenter Oncologie Clinica S.R.L, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in S.C Oncocenter Oncologie Clinica S.R.L, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".